BioIVT adds transporter assay products and services to its ADME-Toxicology portfolio with the acquisition of Optivia Biotechnology – a deal which aligns with the company’s efforts to support drug safety and efficacy, says VP.
Articles comparing CEO salaries are ten-a-penny at outsourcing publications these days as they use readily available data, are quick to compile and – to be frank – generate the strong web traffic that advertisers love.
Frank Torti has been appointed to the newly created post of chief
scientist at the FDA, with a brief to "oversee, coordinate, and
ensure quality and regulatory focus of the intramural research
The US Food and Drug Administration (FDA) has outlined a new draft
plan designed to better enable it to flex its postmarketing muscle
which will significantly increase the number of employees that
focus on drug safety issues and post-market...
A bill aimed at tightening up the Food and Drug Administration's
oversight of prescription drug safety moved one small step closer
to the statute books late last week after it passed the Senate
Health, Education, Labor and Pensions...